Harvard Bioscience Pre-Tax Profit Margin 2010-2024 | HBIO

Harvard Bioscience pre-tax profit margin from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Harvard Bioscience Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2024-12-31 $0.10B $-0.01B -10.53%
2024-09-30 $0.10B $-0.01B -12.24%
2024-06-30 $0.10B $-0.01B -8.91%
2024-03-31 $0.11B $-0.01B -7.48%
2023-12-31 $0.11B $0.00B -2.68%
2023-09-30 $0.11B $0.00B -2.68%
2023-06-30 $0.11B $-0.01B -6.14%
2023-03-31 $0.11B $0.00B -1.75%
2022-12-31 $0.11B $-0.01B -8.85%
2022-09-30 $0.12B $-0.01B -6.78%
2022-06-30 $0.12B $0.00B -2.48%
2022-03-31 $0.12B $-0.01B -5.79%
2021-12-31 $0.12B $0.00B -0.84%
2021-09-30 $0.12B $0.00B -2.56%
2021-06-30 $0.11B $0.00B -3.60%
2021-03-31 $0.11B $0.00B -3.81%
2020-12-31 $0.10B $-0.01B -6.86%
2020-09-30 $0.10B $-0.01B -5.88%
2020-06-30 $0.11B $-0.01B -7.62%
2020-03-31 $0.11B $-0.01B -7.14%
2019-12-31 $0.12B $-0.01B -5.17%
2019-09-30 $0.12B $-0.01B -5.04%
2019-06-30 $0.12B $0.00B -3.31%
2019-03-31 $0.12B $-0.01B -4.07%
2018-12-31 $0.12B $-0.01B -6.56%
2018-09-30 $0.11B $-0.01B -7.27%
2018-06-30 $0.10B $-0.01B -8.00%
2018-03-31 $0.09B $-0.01B -8.05%
2017-12-31 $0.08B $0.00B -3.85%
2017-09-30 $0.08B $0.00B -4.88%
2017-06-30 $0.09B $0.00B -4.55%
2017-03-31 $0.10B $0.00B -4.21%
2016-12-31 $0.10B $0.00B -2.88%
2016-09-30 $0.11B $0.00B -1.89%
2016-06-30 $0.11B $0.00B -1.87%
2016-03-31 $0.11B $0.00B -0.91%
2015-12-31 $0.11B $0.00B -2.75%
2015-09-30 $0.11B $0.00B -1.80%
2015-06-30 $0.11B 0 0.00%
2015-03-31 $0.11B $0.00B 0.93%
2014-12-31 $0.11B $0.00B 3.70%
2014-09-30 $0.11B $0.00B 1.89%
2014-06-30 $0.11B $0.00B 0.94%
2014-03-31 $0.11B 0 0.00%
2013-12-31 $0.11B 0 0.00%
2013-09-30 $0.11B $0.01B 5.71%
2013-06-30 $0.11B $0.01B 5.66%
2013-03-31 $0.11B $0.01B 6.48%
2012-12-31 $0.11B $0.01B 6.36%
2012-09-30 $0.11B $0.01B 4.50%
2012-06-30 $0.11B $0.01B 4.50%
2012-03-31 $0.11B $0.01B 5.45%
2011-12-31 $0.11B $0.01B 6.48%
2011-09-30 $0.11B $0.01B 6.42%
2011-06-30 $0.11B $0.01B 8.26%
2011-03-31 $0.11B $0.01B 8.33%
2010-12-31 $0.11B $0.01B 9.26%
2010-09-30 $0.11B $0.01B 12.26%
2010-06-30 $0.10B $0.01B 11.88%
2010-03-31 $0.09B $0.01B 10.75%
2009-12-31 $0.09B $0.01B 10.47%
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.041B $0.112B
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Stock Name Country Market Cap PE Ratio
Bruker (BRKR) United States $7.866B 21.53
Kewaunee Scientific (KEQU) United States $0.156B 11.44